CXCR3 and cancer: Whereas, it also reminds us when combined NK cell-based ACT and radiotherapy in solid tumor treatment, we should detect CXCR3 and its ligands expression in cancer cells, and pathways (as Ras/ERK or PI3K/AKT) inhibitors should be introduced to prevent tumor metastasis in time.